Copyright
©The Author(s) 2018.
World J Gastroenterol. Mar 28, 2018; 24(12): 1353-1360
Published online Mar 28, 2018. doi: 10.3748/wjg.v24.i12.1353
Published online Mar 28, 2018. doi: 10.3748/wjg.v24.i12.1353
n | Therapy | SVR24 |
5 | IFN + SOF + RBV | 4/5 (80.0%) |
8 | SOF + RBV | 6/8 (75.0%) |
9 | DAC +SOF + RBV | 9/9 (100.0%) |
1 | DAC + SOF | 1/1 (100.0%) |
13 | LDV + SOF + RBV | 13/13 (100.0%) |
2 | LDV + SOF | 2/2 (100.0%) |
1 | SIM + SOF + RBV | 1/1 (100.0%) |
- Citation: Rupp C, Hippchen T, Neuberger M, Sauer P, Pfeiffenberger J, Stremmel W, Gotthardt DN, Mehrabi A, Weiss KH. Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus. World J Gastroenterol 2018; 24(12): 1353-1360
- URL: https://www.wjgnet.com/1007-9327/full/v24/i12/1353.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i12.1353